L-Carnitina|Acetil L-Carnitina|Propionil L-Carnitina
L-Carnitina pura
de (Baza)
De remarcat: L-Carnitina pura de (Baza) 250 mg
este echivalent fata de derivatii sai,
cu:
L-Carnitina Tartrat 375 mg, sau
L-Carnitina Fumarat 427 mg
| L-Carnitina miracol promoveaza: Energie, Reducerea greutatii corporale,
Cardio sanatate, Wellness cerebral, Longevitate |
 |
2. L-Carnitina creste
energia si vitalitatea organismului, are efect la metabolismul acizilor
grasi prin transportul acizilor
grasi catre mitocondrii unde este transformata in
energie ATP, participa la reducerea lipidica hepatica si cresterea
musculara cu reducerea greutatii
corporale
| L-Carnitina creste energia si vitalitatea organismului |
 |
3. L-Carnitina in disfunctia mitocondriala
4. L-Carnitina
cu efect metabolic in reducerea rapida a grutatii corporale in obezitate
5. L-Carnitina cu actiune de protectie renala
datorita la fructoza care induce sindromul metabolic
6. Rolul de L-Carnitina in metabolismul acizilor grasi si in ischemia
miocardului
7. L-Carnitina un aminoacid derivat esential care se gaseste in aproape
toate celulele organismului.
| L-Carnitina transporta acizi grasi cu catena lunga in mitocondria
unde prin oxidare sint transformati in energie sub forma de adenozintrifosfat |
 |
8. L-Carnitina metabolism si sindromul
de deficienta
9. L-Carnitina cu efect la glicarea proteinelor si in pre cataracta lentilei
indusa de fructoza
10. L-Carnitina inhiba glicarea proteinelor in vitro si in vivo cu rol in
managementul diabetului
11. Deficienta sistemica
de L-Carnitina este cauza mutatiei genetice a ionului de sodiu, dependent
de Carnitina cu functie transport - OCTN2
12. Deficienta de L-Carnitina, acidemia
organica si sindromul Reye
Carnitina ia o marja de siguranta (buffer) a metabolitilor acil COA,
Carnitina induce excretia grupei acil care este toxica in urina
13. Deficienta de L-Carnitina si deficienta
de palmitoil transferaza, o alta anomalie
a
transportului
de
acizi
grasi
Deficenta de L-Carnitina are multe cauze:
-
Defecte genetice,
-
Defecte
de metabolism ca metilmalonic aciduria,
-
Deficienta de citocrom C oxidaza,
-
Deficienta de
acizi grasi acil coenzima A dehidrogenaza,
-
Acidemia metilmalonica,
-
Acidemia izovalerica,
-
Acidemia propionica,
-
Aciduria
glutarica,
-
Deficienta din cauza inbatriniri
14. L-Carnitina cu efect in exercitiu
fizic si energie la rezistenta atletilor antrenati, studiu randomizat dublu
orb
placebo controlat
15. L-Carnitina
cu efect in raspunsul androgenic la rezistenta
antrenamentului
16. Evidenta morfometrica,
L-Carnitina cu efect trofic la fibrele musculare
tip 1
17. L-Carnitina cu efect
selectiv trofic la fibrele musculare tip 1 si
fibrele musculare tip 2
18. L-Carnitina in metabolism
previne acidoza musculara si inbunatateste fluxul sanguin
19. Metabilosmul L-Carnitinei
in functia umana
20. L-Carnitina cu efect
favorabil in refacerea rapida dupa efort
21. L-Carnitina in tratamentul:
Sindromul de oboseala cronica CFS
22. L-Carnitina in tratamentul
pacientilor cu boala vasaculara periferica, Carnitina creste
distanta de mers pe jos, studiu randomizat dublu orb
placebo controlat
23. Deficienta de L-Carnitina
la boala vasaculara periferica
24. L-Carnitina are efect la pacienti
cu hiperemia reactiva afectati de boala vasaculara periferica, studiu randomizat
dublu orb
placebo controlat
25. Farmacocinetica la
L-Carnitina
26. L-Carnitina
cu potential terapeutic
in bolile cardiovasculare
| L-Carnitina cu potential terapeutic
in bolile cardiovasculare |
 |
27. L-Carnitina
si Propionil L-Carnitina cu efect terapeutic in bolile cardiovasculare:
Reviu
28. L-Carnitina
creste
performanta pe ergometru la pacienti cu insuficienta cardiaca
29. L-Carnitina administrata
la pacienti cu insuficienta cardiaca
30. L-Carnitina in suspectul de infarct miocardic acut,
studiu randomizat dublu orb
placebo controlat
31. L-Carnitina
cu toleranta in exercitiu la angina cronica stabila, studiu randomizat dublu
orb
placebo controlat
32. L-Carnitina
si derivatii sai cu efect in functia cardiaca postischemica si fibrilatia
ventriculara
la aritmie cardiaca
| Aritmie cardiaca |
 |
33. L-Carnitina
reduce nivelul plasmatic de Lipoproteina (apoa) la pacienti cu hiper Lipoproteina
(apoa)
| L-Carnitina reduce nivelul plasmatic de Lipoproteina (apoa)
la pacienti cu hiper Lipoproteina (apoa) |
 |
L-Lizina are activitate de teflon pentru a inpiedica depunerea pe
peretele vascular de Lipoproteina
(apoa)
34. L-Carnitina are efect de a reduce
valorile ale lipoproteinelor cu densitate joasa (colesterolul-LDL)
35. L-Carnitina in terapia de dislipidemie
36. L-Carnitina la copii cu metabolismul lipidic si cu hemodializa
37. L-Carnitina are efect favorabil
in tratamentul de hipertrigliceridemia pacienti cu hemodializa: rol decisiv
il are nivelul scazut de HDL-colesterol
38. L-Carnitina cu efect la nivelul
seric de HDL-colesterol
39. L-Carnitina amelioreaza
efectul alcoolului care induce steatoza hepatica
40. L-Carnitina referinte
medicale
41. L-Carnitina in hiperfunctia de glanda tiroida
42. L-Carnitina cu efect in hiperfunctia de glanda tiroida
43. L-Carnitina un natural inhibitor hormonului tiroidean T 3 si
T 4
44. L-Carnitina controleaza statusul hormonului tiroidean
45. L-Carnitina cu efect la acumularea de iod in glanda
tiroida
L-Carnitina cu efect in hiperfunctia de glanda tiroida
46. L-Carnitina inhiba in mod natural hormonul de glanda
tiroida
47. Acetil L-Carnitina un Star poate suplimentar trece bariera hepatoencefalica,
este involvat ca mijloc de transport de L-Carnitina si poate restaura nivelul
scazut de L-Carnitina in cerebral
48. In deficienta de L-Carnitina la pacienti cu cancer avansat
49. L-Carnitina cu siguranta si tolerabil la
pacienti cu cancer, sindrom de oboseala cronica (CFS)
Terapia Anti Aging:
 Anti-Aging-Systeme
- Formula AntiAging
Bibliografie - References: Referinte L-Carnitina
Informatii din bibliografia electronica la tema: Nutritie si sanatate
1. Blanchard G, Paragon BM, Milliat F, Lutton C. Dietary L-carnitine supplementation
in obese cats alters carnitine metabolism and decreases ketosis during fasting
and induced hepatic lipidosis. UP de Nutrition, Ecole Nationale Veterinaire
d'Alfort, 94704 Maisons Alfort, France. blanchard@vet-alfort.fr J Nutr. 2002
Feb;132(2):204-10.
2. Ibrahim WH, Bailey N, Sunvold GD, Bruckner GG. Effects of carnitine and taurine
on fatty acid metabolism and lipid accumulation in the liver of cats during weight
gain and weight loss. Department of Clinical Sciences/Clinical Nutrition, College
of Health Sciences, University of Kentucky, Lexington, KY 40536, USA. Am J Vet
Res. 2003 Oct;64(10):1265-77.
3. Binienda ZK. Neuroprotective effects of L-carnitine in induced mitochondrial
dysfunction. Neurophysiology Laboratory, Division of Neurotoxicology, National
Center for Toxicological Research/FDA, Jefferson, Arkansas 72079, USA.Ann N
Y Acad Sci. 2003 May;993:289-95; discussion 345-9.
4. Center SA, Harte J, Watrous D, Reynolds A, Watson TD, Markwell PJ, Millington
DS, Wood PA, Yeager AE, Erb HN. The clinical and metabolic effects of rapid
weight loss in obese pet cats and the influence of supplemental oral L-carnitine.
Department
of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca,
NY 14853, USA.
sac6@cornell.edu J Vet Intern Med. 2000 Nov-Dec;14(6):598-608.
5. Rajasekar P, Viswanathan P, Anuradha CV. Renoprotective action
of L-carnitine in fructose-induced metabolic syndrome. Department of Biochemistry
and Biotechnology, Faculty of Science, Annamalai University, Tamil Nadu, India.
Diabetes Obes Metab. 2008 Feb;10(2):171-80. Epub 2007 Dec 17.
6. Opie LH. Role of carnitine in fatty acid metabolism of normal and ischemic
myocardium. Am Heart J. 1979 Mar;97(3):375-88.
7. Borum PR, Bennett SG. Carnitine as an essential nutrient. J Am
Coll Nutr 1986;5:177-82.
8. Rebouche CJ, Engel AG. Carnitine metabolism and deficiency syndromes.
Mayo Clin Proc. 1983 Aug;58(8):533-40.
9. Balasaraswathi K, Rajasekar P, Anuradha CV. Changes in redox ratio and
protein glycation in precataractous lens from fructose-fed rats: effects
of exogenous L-carnitine. Department of Biochemistry and Biotechnology, Annamalai
University, Annamalai Nagar, Tamil Nadu, India. Clin Exp Pharmacol Physiol.
2008 Feb;35(2):168-73. Epub 2007 Oct 17.
10. Rajasekar P, Anuradha CV. L-Carnitine inhibits protein glycation in vitro
and in vivo: evidence for a role in diabetic management. Department of Biochemistry
and Biotechnology Faculty of Science, Annamalai University, Annamalai Nagar,
608 002, Tamil Nadu, India, Acta Diabetol. 2007 Jun;44(2):83-90. Epub 2007 May
27.
11. Nezu J, Tamai I, Oku A, et al. Primary systemic carnitine deficiency
is caused by mutations in a gene encoding sodium ion-dependent carnitine
transporter.
Nat
Gen. 1999; 21:91-94.
12. Stumpf DA, Parker WD Jr, Angelini C. Carnitine deficiency, organic
acidemias, and Reye's syndrome. Neurology. 1985 Jul;35(7):1041-5.
13. Angelini C. Alterations of mitochondria in metabolic diseases. Carnitine
deficiency, carnitine palmitoyltransferase deficiency and beta oxidation.
Acta Neurol (Napoli).
1989
Oct;11(5):330-4.
14. Colombani P, Wenk C, Kunz I, Krahenbuhl S, Kuhnt M, Arnold M, Frey-Rindova
P, Frey W, Langhans W. Effects of L-carnitine supplementation on physical
performance and energy metabolism of endurance-trained athletes: a double-blind
crossover
field study. INW Gruppe Ernahrungsbiologie, ETH Zentrum, Zurich, Switzerland.
Eur J Appl Physiol Occup Physiol. 1996;73(5):434-9.
15. Kraemer WJ, Spiering BA, Volek JS, Ratamess NA, Sharman MJ, Rubin
MR, French DN, Silvestre R, Hatfield DL, Van Heest JL, Vingren JL, Judelson
DA, Deschenes
MR, Maresh CM. Androgenic responses to resistance exercise: effects of
feeding and L-carnitine. Human Performance Laboratory, Department of
Kinesiology,
University of Connecticut, Storrs, CT 06269-1110, USA. William.Kraemer@uconn.edu
Med Sci
Sports Exerc. 2006 Jul;38(7):1288-96.
16. Spagnoli LG, Palmieri G, Mauriello A, Vacha GM, D'Iddio S, Giorcelli
G, Corsi M. Morphometric evidence of the trophic effect of L-carnitine
on human
skeletal
muscle. Cattedra di Anatomia Patologica, II Universita di Roma 'Tor Vergata',
Italy. Nephron. 1990;55(1):16-23
17. Giovenali P, Fenocchio D, Montanari G, Cancellotti C, D'Iddio S,
Buoncristiani U, Pelagaggia M, Ribacchi R. Selective trophic effect of
L-carnitine in
type I and IIa skeletal muscle fibers. II Cattedra Anatomia Istologia
Patologica, Universita di Perugia, Italy. Kidney Int. 1994 Dec;46(6):1616-9.
18. HFClsmann WC, Dubelaar M-L. Carnitine in metabolism of paced cardiac
and skeletal muscles: prevention of acidosis and improvement of vascular
flow.
In: Ferrari R, DiMauro S, Sherwood G, eds. L-Carnitine and its Role in
Medicine: From Function
to Therapy. London, UK: Academic Press, 1992:345-358.
19. Rebouche CJ, Paulson DJ. Carnitine metabolism and function in humans.
Annu Rev Nutr. 1986;6:41-66.
20. Volek JS, Kraemer WJ, Rubin MR, Gomez AL, Ratamess NA, Gaynor P.
L-Carnitine L-tartrate supplementation favorably affects markers of recovery
from exercise
stress. Human Performance Laboratory, Department of Kinesiology, University
of Connecticut, Storrs, Connecticut 06269, USA. jvolek@uconnvm.uconn.edu
Am J Physiol
Endocrinol Metab. 2002 Feb;282(2):E474-82.
21. Plioplys AV, Plioplys S. Amantadine and L-carnitine treatment of
chronic fatigue syndrome. Chronic Fatigue Syndrome Center, Department
of Research,
Mercy Hospital Chicago, Ill 60616, USA. Neuropsychobiology. 1997;35(1):16-23.
22. Brevetti G, Chiariello M, Ferulano G, Policicchio A, Nevola E, Rossini
A, Attisano T, Ambrosio G, Siliprandi N, Angelini C. Increases in walking
distance in patients with peripheral vascular disease treated with L-carnitine:
a double-blind,
cross-over study. Department of Medicine, Second Medical School, University
of
Naples, Italy. Circulation. 1988 Apr;77(4):767-73.
23. Brevetti G, Angelini C, Rosa M, Carrozzo R, Perna S, Corsi M, Matarazzo
A, Marcialis A. Muscle carnitine deficiency in patients with severe peripheral
vascular
disease. Department of Medicine, University of Naples Federico II, Italy.
Circulation. 1991 Oct;84(4):1490-5.
24. Brevetti G, Attisano T, Perna S, et al. Effect of L-carnitine on
the reactive hyperemia in patients affected by peripheral vascular disease:
a double-blind,
crossover study. Angiology. 1989;40(10):857-862.
25. Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Centre for
Pharmaceutical Research, School of Pharmaceutical, Molecular and Biomedical
Sciences, University
of South Australia, Adelaide, South Australia, Australia. allan.evans@unisa.edu.au
Clin Pharmacokinet. 2003;42(11):941-67.
26. Pepine CJ. The therapeutic potential of carnitine in cardiovascular
disorders. Division of Cardiology, University of Florida, Gainesville.
Clin
Ther.
1991 Jan-Feb;13(1):2-21
27. Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C. Therapeutic
effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases:
a review. Chair of Cardiology, University Hospital of Ferrara, Gussago
(Brescia), Italy. fri@dns.unife.it Ann N Y Acad Sci. 2004 Nov;1033:79-91.
28. Loster H, Miehe K, Punzel M, Stiller O, Pankau H, Schauer J. Prolonged
oral L-carnitine substitution increases bicycle ergometer performance
in patients with severe, ischemically induced cardiac insufficiency.
Institute
of Clinical
Chemistry and Pathobiochemistry, University of Leipzig, Germany. Cardiovasc
Drugs
Ther. 1999 Nov;13(6):537-46.
29. Rizos, I. Three-year survival of patients with heart failure caused
by dilated cardiomyopathy and L-carnitine administration. University
of Athens
Medical School,
Greece.
Am Heart J. 2000 Feb;139(2 Pt 3):S120-3.
30. Singh RB, Niaz MA, Agarwal P, Beegum R, Rastogi SS, Sachan DS.
A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected
acute myocardial infarction. Heart Research Laboratory, Medical Hospital and
Research Centre, Moradabad, India. Postgrad Med J. 1996 Jan;72(843):45-50.
31. Cherchi A., Lai C, Angelino F, Trucco G, Caponnetto S, Mereto PE,
Rosolen G, Manzoli U, Schiavoni G, Reale A, et al. Effects of L-carnitine
on exercise
tolerance in chronic stable angina: a multicenter, double-blind, randomized,
placebo controlled crossover study. Int J Clin Pharmacol Ther Toxicol
1985 Oct;23(10):569-72.
32. Cui J, Das DK, Bertelli A, Tosaki A. Effects of L-carnitine and
its derivatives on postischemic cardiac function, ventricular fibrillation
and necrotic and
apoptotic cardiomyocyte death in isolated rat hearts. Cardiovascular
Research Center, University
of Connecticut School of Medicine, Farmington, CT 06030-1110, USA.
Mol
Cell Biochem. 2003 Dec;254(1-2):227-34.
33. Sirtori, C. R., L. Calabresi, S. Ferrara, F. Pazzucconi, A. Bondioli,
D. Baldassarre, A. Birreci and A. Koverech. L-carnitine reduces plasma
lipoprotein(a) levels in patients with hyper Lp(a). Center E. Grossi
Paoletti, Institute
of
Pharmacological Sciences, University of Milano, Italy. Nutr Metab Cardiovasc
Dis 10(5): 247-51.
34. Maebashi M, Kawamura N, Sato M, et al. Lipid-lowering effects of
carnitine in patients with type-IV hypolipoproteinaemia. Lancet. 1978;
2:805-807.
35. Pola P, Savi L Grilli M, et al. Carnitine in the therapy of dyslipidemic
patients. Curr Therapeu Res. 1980; 27:208-216.
36. Glöggler A, Bulla M, Fürst P. Effect of low dose supplementation of L-carnitine
on lipid metabolism in hemodialyzed children. Institute of Biological Chemistry
and Nutrition, University of Hohenheim, Stuttgart, Federal Republic of Germany.
Kidney Int Suppl. 1989 Nov;27:S256-8.
37. Vacha GM, Giorcelli G, Siliprandi N, Corsi M. Favorable effects
of L-carnitine treatment on hypertriglyceridemia in hemodialysis
patients: decisive role
of low levels of high-density lipoprotein-cholesterol. Am J Clin
Nutr. 1983 Oct;38(4):532-40.
38. Rossi CS, Siliprandi N. Effects of carnitine on serum HDL-cholesterol:
report of two cases. Johns Hopkins Med J. 1982 Feb;150(2):51-4.
39. Sachan DS, Rhew TH, Ruark RA. Ameliorating effects of carnitine
and its precursors on alcohol-induced fatty
liver. Am J Clin Nutr. 1984 May;39(5):738-44.
40. Levocarnitine. Physicians' Desk Reference. 54 ed. Montvale, NJ;
Medical Economics Company. 2000:2957-2959.
41. Strack E, Bloesche H, Bemm H, Rotzsch W. Use of L-carnitine in
hyperfunction of the thyroid gland. Dtsch Z Verdau Stoffwechselkr.
1962 Apr;21:253-9.
42. Strack E, Woratz G, Rotzsch W. Effects of carnitine in hyperfunction
of the thyroid gland. Endokrinologie. 1959 Sep;38:218-25.
43. Benvenga S, Lakshmanan M, Trimarchi F. Carnitine is a naturally
occurring inhibitor of thyroid hormone nuclear uptake. Thyroid. 2000
Dec;10(12):1043-50.
44. Galland S, Georges B, Le Borgne F, Conductier G, Dias JV, Demarquoy
J. Thyroid hormone controls carnitine status through modifications
of gamma-butyrobetaine hydroxylase activity and gene expression.
Cell Mol
Life Sci. 2002 Mar;59(3):540-5.
45. Willgerodt H, Rotzsch W, Strack E. Effect of carnitine of the
accumulation of iodine in the thyroid gland. Dtsch Z Verdau Stoffwechselkr.
1965
Aug;25(3):127-35.
46. Benvenga S, Lakshmanan M, Trimarchi F. Carnitine is a naturally
occurring inhibitor of thyroid hormone nuclear uptake. Thyroid. 2000
Dec;10(12):1043-50.
47. Inano A, Sai Y, Nikaido H, Hasimoto N, Asano M, Tsuji A, Tamai
I. Acetyl-L-carnitine permeability across the blood-brain barrier
and involvement
of carnitine
transporter OCTN2. Faculty of Pharmaceutical Sciences, Kanazawa University,
13-1 Takara-machi,
Kanazawa 920-0934, Japan. Biopharm Drug Dispos. 2003 Nov;24(8):357-65.
48. Cruciani RA, Dvorkin E, Homel P, Culliney B, Malamud S, Lapin
J, Portenoy RK, Esteban-Cruciani N. L-carnitine supplementation in patients
with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled
study. Research Division, Department of Pain Medicine and Palliative Care,
Beth Israel Medical Center, New York, NY 10003, USA. J Pain Symptom Manage.
2009 Apr;37(4):622-31. Epub 2008 Sep 21.
49. Cruciani RA, Dvorkin E, Homel P, Malamud S, Culliney B, Lapin J,
Portenoy RK, Esteban-Cruciani N. Safety, tolerability and symptom outcomes
associated
with L-carnitine supplementation in patients with cancer, fatigue, and
carnitine deficiency: a phase I/II study. Department of Pain Medicine and
Palliative
Care, Beth Israel Medical Center, New York 10003, USA. J Pain Symptom Manage.
2006 Dec;32(6):551-9.
Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.
|
L-Carnitina este responsabila pentru transportul acizilor grasi in invelisul mitocondrial hialoplasma (citosol) si organitele intracelulare unde se transforma in energie ATP. 
